In our study, changes in anti-GFAP AAb level were positively associated with worse mental component score in the ME/CFS(+)FM group and with illness duration in the ME/CFS(−)FM group. This evidence concerns the gene GFAP and myalgic encephalomeyelitis/chronic fatigue syndrome.